Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of polymorphisms in HPC2/ELAC2 and SRD5A2 genes with benign prostate hyperplasia in Turkish men.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2011

Izmirli Muzeyyen, Arikan Burhan, Bayazit Yildirim, Alptekin Davut

Abstract excerpt

Benign prostate hyperplasia (BPH) is the most common benign tumor in elderly men for which the HPC2/ELAC2 and SRD5A2 genes are known genetic factors. The HPC2/ELAC2 gene features Ser217Leu and Ala541Thr polymorphisms and the SRD5A2 gene Ala49Thr and Val89Leu polymorphisms. The aim of this study was to examine relationships between these polymorphisms and BPH in Turkish men using amplification by the polymerase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Membrane Proteins

Share to Neoplasm Proteins

Share to Polymorphism, Restriction Fragment Length

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Share to Turkey

Source

Identifiers

PMID: 21627373

Genes

ELAC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of polymorphisms in HPC2/ELAC2 and SRD5A2 genes with benign prostate hyperplasia in Turkish men.PMID 21627373Read ↗

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Single Nucleotide Polymorphisms Associated With Prostate Cancer Development in Saudi MalesSemantic proximity Read ↗

Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men.Semantic proximity Read ↗

Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.Semantic proximity Read ↗

Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population.Semantic proximity Read ↗

[Genetic polymorphisms in benign prostatic hyperplasia: Progress in studies].Semantic proximity Read ↗

ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.Semantic proximity Read ↗

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications.Semantic proximity Read ↗

Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Association of benign prostate hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men.Semantic proximity Read ↗

Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.Semantic proximity Read ↗

Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.